BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24389388)

  • 1. Mimicry between intestinal Behçet's disease and inflammatory bowel disease.
    Rodrigues-Pinto E; Magro F; Pimenta S; Guimarães J; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):714-5. PubMed ID: 24389388
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS; Gavin MP; Sturrock RD
    Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
    Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.
    Jalili A; Kinaciyan T; Barisani T; Peck-Radosavljevic M; Stingl G; Geusau A; Wöhrl S
    Iran J Immunol; 2009 Mar; 6(1):55-8. PubMed ID: 19293479
    [No Abstract]   [Full Text] [Related]  

  • 5. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
    Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
    J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J; Cheon JH
    Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behcet's refractory uveitis treated successfully by infliximab].
    Mahfoudhi M; Hariz A; Ben Abdelghani K; Turki S; Kheder A
    Tunis Med; 2014 Jan; 92(1):41-2. PubMed ID: 24879172
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease.
    Kluger N; Poirier P; Guilpain P; Baixench MT; Cohen P; Paugam A
    Int J Infect Dis; 2009 Sep; 13(5):e325. PubMed ID: 19157948
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract]   [Full Text] [Related]  

  • 11. Behçet's colitis.
    Hokama A; Yamashiro T; Kinjo F; Saito A
    Gastrointest Endosc; 1999 Feb; 49(2):239. PubMed ID: 9925704
    [No Abstract]   [Full Text] [Related]  

  • 12. Infliximab monotherapy for neuro-Behçet's disease: a case report.
    Di Filippo M; Di Gregorio M; Nannini C; Gaetani L; Gallina C; Floridi P; Sarchielli P; Calabresi P; Cantini F
    J Neurol Sci; 2014 Dec; 347(1-2):389-90. PubMed ID: 25456463
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.
    Olivieri I; Latanza L; Siringo S; Peruz G; Di Iorio V
    J Rheumatol; 2008 May; 35(5):930-2. PubMed ID: 18464316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening of osteomalacia in a patient successfully treated for neuro-Behçet's disease with infliximab.
    Madanat WY; Madanat AY
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S128-9. PubMed ID: 19026133
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab.
    Yamada S; Makino T; Jinnin M; Sakai K; Fukushima S; Inoue Y; Ihn H
    Dermatology; 2013; 227(4):295-8. PubMed ID: 24281360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis triggered by infliximab in a patient with Behçet's disease.
    Kawazoe Y; Sugita S; Yamada Y; Akino A; Miura K; Mochizuki M
    Jpn J Ophthalmol; 2013 Jan; 57(1):95-7. PubMed ID: 23090423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G; Ben-Chetrit E
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
    Kuroda R; Suzuki J; Muramatsu M; Tasaki A; Yano M; Imai N; Serizawa M; Kobari M
    J Neurol; 2013 Dec; 260(12):3167-70. PubMed ID: 24178704
    [No Abstract]   [Full Text] [Related]  

  • 20. Cornelia de Lange syndrome in association with ulcerative colitis: a case report.
    Papiamonis N; Koutroubakis IE
    J Crohns Colitis; 2013 Oct; 7(9):e399-400. PubMed ID: 23587783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.